NASDAQ
28.11.25 | 18:56
6,520 US-Dollar
+0,62 % +0,040
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Profound Medical Corp (2): Profound Medical to roll out Tulsa-AI BPH module | 1 | Stockwatch | ||
| Fr | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| Fr | Profound Medical Corp.: Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO Clinical Data, at RSNA and SUO Meetings | 1 | GlobeNewswire (USA) | ||
| 18.11. | Profound Medical Corp.: Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease | 4 | GlobeNewswire (USA) | ||
| 13.11. | Profound Medical Corp. Profit Declines In Q3 | - | RTTNews | ||
| 13.11. | Profound Medical Corp. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 13.11. | Profound Medical Corp (2): Profound signs Australia, NZ distribution deal | 2 | Stockwatch | ||
| 12.11. | Profound Medical Corp.: Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO to Australia and New Zealand | 421 | GlobeNewswire (Europe) | TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered... ► Artikel lesen | |
| PROFOUND MEDICAL Aktie jetzt für 0€ handeln | |||||
| 12.11. | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 12.11. | Profound Medical inks exclusive Saudi deal for TULSA-PRO and Sonalleve, stock rises | 1 | Seeking Alpha | ||
| 12.11. | Profound Medical Corp (2): Profound signs exclusive Saudi Arabia distribution deal | 1 | Stockwatch | ||
| 11.11. | Profound Medical Corp.: Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO and Sonalleve with Al Faisaliah Medical Systems in Saudi Arabia | 78 | GlobeNewswire (Europe) | Agreement creates runway for Profound's incision-free and radiation-free therapies for the ablation of diseased tissue, to penetrate the largest healthcare market in the Middle East All required regulatory... ► Artikel lesen | |
| 11.11. | Profound Medical: TULSA-PRO-System als Wachstumstreiber auf der Stifel Healthcare Conference | - | Investing.com Deutsch | ||
| 10.11. | Profound Medical Corp.: Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO in Canada from Knight | 129 | GlobeNewswire (Europe) | TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets artificial... ► Artikel lesen | |
| 16.10. | Profound Medical Corp (2): Profound Medical upbeat about Busch Center results | 2 | Stockwatch | ||
| 07.10. | Profound Medical Corp (2): Profound estimates Q3 revenue of $5.2-million (U.S.) | 2 | Stockwatch | ||
| 07.10. | Profound Medical achieves record prelim revenue for third quarter | 1 | Seeking Alpha | ||
| 07.10. | Profound Medical Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 07.10. | Profound Medical Corp.: Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter | 93 | GlobeNewswire (Europe) | TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable... ► Artikel lesen | |
| 25.09. | Raymond James bestätigt "Outperform"-Rating für Profound Medical | 2 | Investing.com Deutsch |
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 42,840 | +0,23 % | BARCLAYS stuft Siemens Healthineers auf 'Positiv' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Siemens Healthineers von 61,00 auf 61,50 Euro angehoben und die Einstufung auf "Overweight" belassen. Die Aktienkurse... ► Artikel lesen | |
| FRESENIUS | 47,330 | -0,06 % | BARCLAYS stuft Fresenius SE auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Fresenius von 54 auf 58 Euro angehoben und die Einstufung auf "Overweight" belassen. Die Aktienkurse der europäischen... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,250 | +0,27 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 51 auf 48 Euro gesenkt und die Einstufung auf "Equal Weight" belassen. Die Aktienkurse der europäischen... ► Artikel lesen | |
| GERRESHEIMER | 26,540 | +5,23 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| ONEMEDNET | 1,830 | +28,87 % | OneMedNet Corporation: OneMedNet to Showcase Transformative New Platform at RSNA 2025 | ||
| BRIGHTSPRING HEALTH SERVICES | 36,150 | -0,90 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 44,540 | -0,40 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hatCarl Zeiss Meditec auf "Overweight" mit einem Kursziel von 52 Euro belassen. Die Aktienkurse der europäischen Medizintechnik-Unternehmen... ► Artikel lesen | |
| PROGYNY | 26,370 | -1,24 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| GENEDX | 166,95 | +0,81 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| ADAPTHEALTH | 9,660 | +0,52 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| LIFESTANCE HEALTH GROUP | 6,500 | -0,91 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BETA BIONICS | 31,340 | +1,56 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,180 | -0,21 % | Alignment Healthcare stock rating upgraded by JPMorgan to Overweight | ||
| PROCEPT BIOROBOTICS | 31,700 | +0,06 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PACS GROUP | 33,395 | +3,84 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |
PROFOUND MEDICAL CORP gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,040 (+0,62 %) liegt der Kurs bei 6,520 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFOUND MEDICAL CORP finden Sie auf Wallstreet Online.